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tifurcation lesions remain an unresolved problem for per-
utaneous coronary intervention (PCI). Broadly defined as
tenoses that involve the origin of an arterial side branch
xceeding 2.0 mm in diameter, bifurcation lesions present a
hallenge to achieve relief of arterial narrowing, deliver
nterventional devices including balloon catheters and
tents, avoid arterial occlusion, and sustain initially success-
ul results.
Part of the complexity in treating bifurcation lesions
elates to the number of different anatomic patterns of
ifurcation stenosis. Given the potential involvement of the
roximal main branch, the distal main branch, and the side
ranch, one classification system identifies at least six
ifferent possible stenosis configurations (1). Furthermore,
here may be major variations in the diameter of each of the
ranches and of the angle at which the side branch origi-
ates from the main branch. Independent of the bifurcation
ype and vessel characteristics, the degree of ostial side
ranch stenosis is the main determinant of the need for side
ranch protection during PCI with a low risk of acute side
ranch occlusion with minimal disease (4%) but a much
igher rate (up to 27%) for significant stenosis (2).
Bifurcation lesions were attempted during the era of
alloon angioplasty. However, inability to achieve consis-
ently a 50% stenosis of both the main branch (e.g., the
eft anterior descending artery) and the side branch (e.g.,
iagonal artery) was obvious a shortcoming. Alternating
hift of plaque or the “isthmus” between the two branches
as one explanation for this failing. Attempts at plaque
olume reduction, with debulking devices such as extraction
r rotational atherectomy, subsequently gained popularity as
djuncts to balloon angioplasty. Such “new device” strate-
ies, however, were technically demanding, occasionally
esulted in serious complications, and were never thoroughly
valuated by comparative randomized trials (3,4). These
onsiderations plus the introduction of intracoronary stents
esulted in the discontinuation of their routine use.
Bare metal stents have been implanted singly or in
ombination in an attempt to improve outcomes. Multiple
ombinations of balloons and stents have been explored
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology. From the Division of Cardiology, Department ofc
edicine, Rhode Island Hospital Brown University School of Medicine, Providence,
hode Island.5–9). Strategies have ranged from a single stent in the main
ranch with or without balloon angioplasty of the side
ranch to two or more stents placed in both the main and
ide branches. In an attempt to ensure complete stent
pposition to the entire surface of the bifurcation plaque, a
pecial concern for drug-eluting stents (DES), stents have
een deployed in an overlapping fashion with one stent
nside or adjacent to the other (5,10). Such approaches
ypically require large guide catheters, simultaneous use of
ore than one balloon catheter, and advanced operator skill
nd experience. Obviously the procedure time and radiation
xposure are longer than otherwise in these instances. On
he positive side, use of stents has clearly improved the
mmediate results of bifurcation angioplasty (8,11). These
enefits even apply to such very complex lesions as those
nvolving the left main, left anterior descending, and cir-
umflex arteries. Almost uniformly the acute angiographic
esults are excellent. Similar benefits have not been ob-
erved, however, during late follow-up, as rates of major
dverse events, in particular restenosis, have been relatively
igh. These mixed results have prompted some to recom-
end a strategy of routine stenting of the main branch with
iscretionary (i.e., only if needed) stenting of the side
ranch (12).
Many expected that the effectiveness of DES for prevent-
ng restenosis in uncomplicated lesions would extend to
ifurcation disease. Although a relative improvement was
bserved, the benefits for bifurcation lesions have not been
s pronounced. In one small observational study of bifurca-
ion DES use, the restenosis rate was 25.7% with recurrence
een primarily at the origin of the side branch (13).
The inclusion of four original reports in this issue of the
ournal provides us with an opportunity to learn more about
he treatment of bifurcation lesions by PCI. One of these is
database analysis of a broad multicenter experience, two
ocus on the two stent “crush” technique, and one discusses
new investigational stent specifically designed for bifurca-
ion lesions (Table 1).
In this issue of the Journal, Garot et al. (14) describe the
n-hospital and nine-month outcomes of 1,412 patients
aving PCI for a bifurcation lesion and compare these
ndings to those of 10,068 patients who had PCI for other
ypes of lesions. This analysis is derived from the database of
he Prevention of Restenosis with Tranilast and its Out-
omes (PRESTO) trial, a randomized clinical trial that
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Editorial Comment August 16, 2005:621–4valuated tranilast, a pharmacologic agent with the potential
o reduce restenosis; PRESTO trial investigators compared
arious dosages of tranilast to placebo and found no effect of
ranilast on outcome (15). In the database comparison
etween bifurcation and other lesions, Garot et al. (14)
ound differences in the prevalence of a few baseline fea-
ures, but in general these differences were small in magni-
ude. Of note, stents were used in only 71% of bifurcation
esions, a rate lower than that for nonbifurcation lesions. At
ine months, incidences of death or myocardial infarction
MI) were similar between the two groups although target
essel revascularization (TVR) by either coronary artery
ypass grafting (CABG) or PCI was higher (17% vs. 14%)
or bifurcation patients. Repeat TVR could be ascribed to
estenosis that was observed more frequently (28% vs. 22%)
mong bifurcation lesions. This report indicates that bifur-
ation PCI is performed commonly, stents are not used
onsistently, the risk of death or MI is not excessive, and
esion recurrence remains a problem. It is important to note
hat this investigation did not include the use of DES and
hat to be included in the study, PCI had to be successful.
his study likely overestimates the periprocedural results of
ifurcation PCI but is a credible benchmark for comparison
f late outcomes.
In this issue of the Journal, Ge et al. (16) describe a
ingle-center, observational experience using the double
tent “crush” technique for bifurcation lesion PCI. The
rush technique was innovated by this group and is a clever
ethod for optimizing complete stent coverage of the entire
laque surface. With this approach, two stents are juxta-
osed across the bifurcation stenosis, one in the main
ranch and one in the side branch. The proximal end of the
ide branch stent extends into the main branch but is not as
roximal as the end of the main branch stent. The side
ranch stent is then deployed. The balloon and wire of that
tent are removed and then the main branch stent is
eployed and crushes the proximal end of the side branch
able 1. Comparison of Bifurcation Lesion Reports
Garot et al. (14) Le
o. patients 1,412
tent type Bare B
o. stents/lesion 1
echnique NA D
uration of follow-up 9 months
B restenosis (%) NA
B restenosis (%) NA
ny restenosis (%) 28
LR (%) NA
VR (%) 17
tent thrombosis (%) NA
eath 1
I 1
ACE 18
MACE (death, MI, TLR); †cardiac death only.
MACE  major adverse cardiac events (death, myocardial infarction [MI], ta
aclitaxel-eluting stent; SB  side branch; SES  sirolimus-eluting stent; TLR  ttent against the artery wall. If final kissing balloon angio- plasty is performed, a balloon catheter is readvanced into the
ide branch and inflated simultaneously with the main
ranch balloon. In this report DES were used for each
atient, and follow-up included coronary angiography at six
o eight months and clinical status at nine months. These
nvestigators also evaluated the influence of performing final
imultaneous “kissing balloon” (double balloons, one in each
tent) angioplasty.
From a technical standpoint, use of a final kissing balloon
a more contemporary adaptation) was associated with a
ower rate of restenosis of both the main and side branches
8.9% and 11.1%, respectively). We are not provided with
he entire cohort rate for any restenosis, but it was at least
1.6%. At nine months target lesion revascularization
TLR) for the entire group was 14.9%, higher than 9.5%
ith final kissing balloon. Importantly, stent thrombosis
as observed in 4.4% of patients. This rate is considerably
igher than the 1% to 2% usually observed with DES (17). No
echnical features were associated with stent thrombosis, while
remature discontinuation of dual antiplatelet therapy was.
Additional insight into the results of the crush technique
s provided by Costa et al. (18) in their intravascular
ltrasound analysis of 40 patients presented in this issue of
he Journal. They observed that the area of the crush (i.e.,
he segment of stent overlap with three adjacent layers of
tent) was most often the narrowest segment within the
ain vessel segment. Incomplete expansion of the crushed
rea was present in the majority of patients, even if the final
issing balloon technique was used. Importantly, although
he number of patients in this study was small, one devel-
ped stent thrombosis and that patient demonstrated “in-
omplete crushing.” Coronary angiography failed to detect
ncomplete stent expansion, and the correlation between
ntravascular ultrasound (IVUS) and quantitative coronary
ngiography was significant, but considerable variability was
bserved.
In this issue of the Journal, Lefèvre et al. (19) describe the
et al. (19) Ge et al. (16) Costa et al. (18)
5 181 40
Frontier SES/PES SES
1 2 2
balloon Crush Crush
onths 9 months Procedural
9.9 11.5 NA
9.1 21.6 NA
4.8 NA NA
3.3 14.9 NA
9.0 17.1 NA
0 4.4 2.5
0 1.1† NA
3.8 11.6 NA
7.1* 26.5 NA
ssel revascularization [TVR]; MB  main branch; NA  not available; PES 
lesion revascularization.fèvre
10
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1erformance and safety of a new investigational stent, the
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August 16, 2005:621–4 Editorial Commentulti-Link Frontier, designed specifically for use in bifur-
ation lesions. This stent system features two balloon
atheters, two guidewires, and a stent that has a portal
nsuring access to the side branch. The stent was success-
ully implanted in 96 of 108 (91%) patients. During the
nitial hospitalization, two patients experienced an MI (one
-wave) and one patient required CABG. By six months,
here were no deaths, 3.8% experienced MI, and 13.3%
LR. The authors concluded that the rates of major adverse
vents for this stent were low.
What are the implications of these reports? Specifically
o they change our perceptions of the effectiveness or safety
f PCI for bifurcation lesions or the manner in which PCI
hould be performed? In terms of effectiveness, these studies
upport prior observations that acute success rates for
chieving excellent relief of bifurcation narrowing as judged
y angiography are high. A less than optimal result, how-
ver, may be experienced with the crush technique.
The durability of this very favorable initial outcome
emains a concern. A comparison of the rates for TVR
etween the reports of Garot et al. (14) (favoring bare metal
tent, provisional side branch stenting) and Ge et al. (16)
sing DES and the crush technique shows no difference,
nd the rates are higher (17% and 17.1%, respectively) than
ith DES for nonbifurcation lesions. Of note, when the
nal kissing balloon technique was added to the DES-crush
pproach, the TVR was reduced to 10.3%. Whether this
ifference represents a true superiority of the DES-crush
pproach over a more conventional approach is unclear.
lso since the Garot et al. (14) experience was limited to
are-metal stents, we have no comparative data about the
utcomes of the main vessel stent-discretionary side branch
trategy using a DES. Additionally, all patients in the study
y Ge et al. (16) had routine angiographic follow-up that
ay have increased the rate of TVR.
Should we expect less restenosis and fewer repeat revas-
ularization procedures when using the new Frontier stent
escribed by Lefèvre et al. (19)? Not necessarily, as the TVR
ate observed after implantation of this side branch access
tent with 43% of patients receiving a side branch stent
ctually appeared to be higher than that of the Garot et al.
14) historical bare-stent group (19.0% vs. 17.0%, respec-
ively). Clearly we must be cautious in direct comparisons of
hese reports, but these observational studies are represen-
ative of the types of information we have available.
The profile of safety, assessed as the occurrence of death,
I, or the need to perform emergency CABG, was favor-
ble in the conventional experience of Garot et al. (14) and
ith the use of the new side branch access stent. Stent
hrombosis, however, was observed in 4.4% the patients
reated by the crush technique. Intraprocedural thrombosis,
hich is exceedingly rare apart from the setting of preex-
sting thrombus (e.g., acute ST-segment elevation MI), was
oted in 1.7%. An additional 2.8% of patients experienced
tent thrombosis by nine months. Importantly, the conse-
uences of stent thrombosis such as MI or death are ofuch greater concern than those of restenosis that typically
resents as recurrent ischemia. The report of Costa et al.
18) is particularly relevant to this issue. They identified an
ssociation between incomplete apposition of stent struts
gainst the main vessel wall in the area of the crush to the
evelopment of stent thrombosis. Moreover, they observed
hat incomplete crushing was observed in the majority of
atients and that the most narrowed area of the main vessel
tent was also at the site of the crush despite 75% of these
atients having had final kissing balloon inflations. Taken
ogether, these observations suggest that the crush tech-
ique inherently creates a structural substrate that increases
he chance for stent thrombosis and that the increase in rate
f stent thrombosis reported by Ge et al. (16) may accurately
eflect a safety concern for this technique.
In the final analysis, we have not yet identified an
ppropriate solution to the problems associated with PCI
or bifurcation lesions. If the crush technique is used, final
issing balloon angioplasty appears essential to optimize
ustained patency, and safety may be enhanced by IVUS-
uided stent deployment. Selecting the crush approach to
educe the incidence of restenosis, however, may incur the
xpense of an increased risk for stent thrombosis. New stent
esigns will be developed for bifurcation lesion intervention
ut must incorporate the benefits of drug elution and ensure
rug availability to all diseased surfaces. Until these objec-
ives are achieved, the simple approach of drug-eluting
tenting of the main branch with provisional stenting of the
ide branch remains a reasonable option with a very accept-
ble profile of safety and effectiveness.
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